High‐Intensity Statin Treatment Is Associated With Reduced Growth Differentiation Factor‐15 in Patients With Coronary Artery Disease
European Journal of Clinical Investigation · 2026-07 · 56 (7)
DOI: 10.1111/eci.70241 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 16.07.2026. Verfasst von Konrad Stępień und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thromboembolic Disorders, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Coronary Artery Disease, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Atorvastatin. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Growth differentiation factor‐15 (GDF‐15) is upregulated in coronary artery disease (CAD). The relationship of intensive statin therapy with circulating GDF‐15 levels has not been explored yet. In the current secondary analysis of an observational cohort, we investigated whether high‐intensity statin treatment is associated with GDF‐15 in patients with advanced CAD.
Methods
In 102 CAD patients we measured GDF‐15 levels before and after median 7 [6–8] months from initiation atorvastatin 80 mg/day ( n = 63, 61.8%) or rosuvastatin 40 mg/day ( n = 39, 38.2%). At the two time points we also determined C‐reactive protein (CRP), thrombin generation and fibrinolysis inhibitors. There was no concurrent control group.
Results
At baseline GDF‐15 levels (median 942; interquartile range 639–1284 pg/mL) were associated solely with age ( R = 0.567, p < 0.001) and CRP ( R = 0.464, p < 0.001), but not with lipid profile. On high‐intensity statin therapy GDF‐15 reduction by 17.8% was observed ( p = 0.006), which was associated with CRP lowering by 46.4% ( R = 0.788, p < 0.001), but not with changes in total cholesterol (by 17.6%) and low‐density lipoprotein cholesterol (LDL‐C) (by 28.1%). However, GDF‐15 levels were lower by 28.5% ( p < 0.001) and 18.9% ( p = 0.013) in 43 patients (42.2%) who achieved the target LDL‐C < 1.8 mmol/L and 19 (18.6%) with LDL‐C < 1.4 mmol/L, respectively, as compared to the remainder. The type of statin was not associated with follow‐up GDF‐15. Age ( p = 0.029), baseline GDF‐15 ( p < 0.001) and CRP ( p < 0.001), but not LDL‐C, were independently associated with follow‐up GDF‐15.
Conclusions
We demonstrated that high‐dose statin therapy is associated with lower GDF‐15 in CAD patients and this effect is largely related to the anti‐inflammatory properties of statins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thromboembolic Disorders, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.
- Department of Coronary Artery Disease and Heart Failure, St. John Paul II Hospital, Kraków, Poland.
- Krakow Center for Medical Research and Technologies, St. John Paul II Hospital, Kraków, Poland.
- Department of Coronary Artery Disease and Heart Failure, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland.
- Department of Pharmacology, Jagiellonian University Medical College, Kraków, Poland.
ORCID-Profile: Michał Ząbczyk
Zitieren
APA
Stępień, K., Ząbczyk, M., Natorska, J., Zalewski, J., Jawień, J., & Undas, A. (2026). High‐Intensity Statin Treatment Is Associated With Reduced Growth Differentiation Factor‐15 in Patients With Coronary Artery Disease. European Journal of Clinical Investigation, 56(7). https://doi.org/10.1111/eci.70241
Vancouver
Stępień K, Ząbczyk M, Natorska J, Zalewski J, Jawień J, Undas A. High‐Intensity Statin Treatment Is Associated With Reduced Growth Differentiation Factor‐15 in Patients With Coronary Artery Disease. European Journal of Clinical Investigation. 2026;56(7). doi:10.1111/eci.70241
BibTeX
@article{Stpie2026,
author = {Stępień, Konrad and Ząbczyk, Michał and Natorska, Joanna and Zalewski, Jarosław and Jawień, Jacek and Undas, Anetta},
title = {High‐Intensity Statin Treatment Is Associated With Reduced Growth Differentiation Factor‐15 in Patients With Coronary Artery Disease},
journal = {European Journal of Clinical Investigation},
year = {2026},
volume = {56},
number = {7},
doi = {10.1111/eci.70241}
}
EUVIMED